Chandarana Lab

Research focus

NIH R01 · 2025

A Path Towards Leveraging AI to Enable Point-of-Care MR Devices for Disease Detection

Project Summary Prostate Cancer (PCA) is the second most prevalent malignancy and a leading cause of mortality among men in the United States. The urgency for early identification of Clinically Significant Prostate Cancer (CSPCA) within the at-risk population cannot be overstated, as it holds the key to significantly enhancing clinical outcomes. Yet, the current standard-of-care for CSPCA surveillance, the Prostate Specific Antigen (PSA) test, is plagued by low specificity, resulting in a cascade of unnecessary advanced diagnostic imaging and invasive biopsy procedures, inflicting a substantial wasteful cost burden on the health system and subjecting patients to avoidable trauma. Despite the…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.